Immunohistochemical Evidence of Lactoferrin in Malignant Gastrointestinal Tumors': A Mini Review








Authored by G Tuccari

Abstract

Lactoferrin (LF), an iron-binding glycoprotein, is well known to have different physiological activities in humans; in normal conditions, it has been found in milk, blood, urine as well as in many external and mucosal secretions. We report herein a mini-review regarding the LF immunohistochemical pattern in gastrointestinal malignant tumours obtained from different human districts in order to acquire a possible explanation for its presence and function.
Keywords: Immunohistochemistry; Lactoferrin; Gastrintestinal; Cancer; Humans

Introduction

Lactoferrin (LF) is an 80kDa glycosylated single chain protein, constituted of ca. 700 amino acids, with high homology among species, present in milk and colostrums as well as in many body fluids, such as blood plasma, amniotic fluid, tears, saliva, semen, bile, urine [1,2]. Several functions have been attributed to LF, although the corresponding mechanisms remain still controversial [3]; it appears involved in the regulation of iron homeostasis and absorption in the bowel as well as in the antimicrobial activity against bacteria, viruses, fungi and parasites [4]. Moreover, immunomodulatory and anti-inflammatory effects of LF have been reported [3,4]. Finally, LF appears to show some enzymatic properties such as protease, DNAase, RNAase and ATPase [5].
Recently, it has been suggested that LF is involved in the regulation of some important processes, such as the cycle and the death of cells, fighting against the carcinogenesis and the development of metastases [6]. In particular, it has been hypothesized that LF inhibits cell proliferation and suppresses tumour growth, blocking the transition from G1 to S in the cell cycle of malignant cells, both in vitro and in vivo [7,8]. Therefore, to better understand the LF anticarcinogenic activity, we report herein an immunohistochemical analysis of LF in human neoplasms of different gastrointestinal district in the attempt to elucidate also its possible pathogenetic role.

Material and Methods

We have reviewed the immunohistochemical pattern of LF distribution in 101 surgical samples obtained from a corresponding number of malignant tumours developed in the stomach (30), colon (39) and gall bladder (32). The study was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki and approved by local ethics committee.
All samples have been fixed in 10% neutral formalin for 24hrs at room temperature (RT) and then embedded in paraffin at 56 °C. Moreover, the bone/cartilage specimens have been decalcified using formic acid 5% or EDTA 5%, pH 7.4, for a period not longer than 48hrs. Depending on the size of mineralised samples. From each block of malignant neoplastic tissue, 4|im-thick sections were stained with haematoxylin/eosin for the microscopic evaluation, but parallel sections were cut and mounted on silane-coated glasses, then dewaxed in xylene and rehydrated in graded ethanols. Antigen retrieval was performed before adding primary antibody by heating slides placed in 0.01 M citrate buffer, pH 6.0, in a microwave oven for three cycles x 5min.
For the immunohistochemical study, sections were treated in a moist chamber at room temperature:
  1. with 0.1% H2O2 in methanol to block the intrinsic peroxidase activity (30min);
  2. with normal sheep serum to prevent unspecific adherence of serum proteins (30min);
  3. with the monoclonal primary antibody against antihuman LF (clone 1A1; Biodesign International, Saco, ME; w.d. 1: 75; 60min);
  4. with sheep anti-mouse immunoglobulin antiserum (Behring Institute; w.d. 1: 25;30min);
  5. with mouse anti-horseradish peroxidase-antiperoxidase complexes (Dako Cytomation, w.d. 1: 25; 30min).
For the demonstration of peroxidase activity, the sections were incubated in darkness for 10 min with 3-3' diaminobenzidine tetra hydrochloride (Sigma Chemical Co., St Louis, MO), in the amount of 100 mg in 200 ml 0.03% hydrogen peroxide in phosphate- buffered saline (PBS). The nuclear counterstain was performed by Mayer's haemalum. Renal tubular structures within normal kidney samples as well as portions of parotid gland were utilised as additional positive controls, as elsewhere suggested [7,8]. The LF immunoreactivity demonstrated in granules of polymorphonuclear neutrophils was utilised as positive control. Finally, in order to test the inter-run variability of LF staining, the same LF-positive parotid sample was utilised in every run. To test the specificity of LF immunostaining in order to deny the possibility of non-specific reaction, serial sections of each neoplastic specimen were tested by replacing the specific antiserum by either PBS, normal rabbit serum or absorbing with excess of purified human LF from human liver and spleen (Sigma Chemical Co.) as well as with pre-absorbed primary antibody: the results obtained were negative.

Immunostained sections were estimated by light microscopy using an x20 and x40 objective lens and x10 eyepiece; the assessment of LF immunostained sections was performed on a consensus basis by two pathologists using a double-headed microscope.

Results and Discussion

All neoplastic samples, routinely stained by haematoxylin and eosin, exhibited a good morphology, confirming the histopatological diagnosis; however, parallel sections were adequately stained by LF immunohistochemistry, with an immunoreactivity generally localized in the cytoplasm but occasionally in the nucleus.

The mucous neck cells of the antrum and body of the stomach were positive for LF; moreover, an evident LF immunoreactivity was encountered in intestinal type carcinomas, whereas diffuse type ones were always unstained. A clear intense cytoplasmatic immunopositivity for LF was found in well and moderately differentiated colo-rectal adenocarcinomas as well as mucinous carcinomas, even if some undifferentiated cases were unreactive; the LF immunostaining was also encountered in neoplastic elements present in metastatic lymphnodes, when the primary cancer was stained.

In gallbladder, a positive LF immunoreactivity was found in a variable share of adenocarcinomas, mainly represented in papillary or glandular areas, while sarcomatoid, squamous or mucinous components were negative; the number of immunostained elements as well as the staining intensity showed some differences in the context of the same tumour. (Figure 1)

In the present study, we have analyzed LF immunoexpression in a series of human gastrointestinal malignant tumours, showing that LF presence was not exclusively localized to the cytoplasm, but also in the nucleus. However, the site of LF immunolocalization in both the nucleus and cytoplasm has not been considered surprising since this glycoprotein has been thought to be involved in ribosomal biogenesis and after its transport into the nucleus; LF is able to bind specific DNA sequences, thus activating transcription [9]. Moreover, we have shown that heterogeneity in LF immunoexpression between different malignancies as well as inside the same tumour were not infrequent; if this observation could reflect different cell subpopulations, the stage in the cell cycle or instead some metabolic abnormalities should be verified by methods other than morphological analysis [10-19].

The origin of LF in human malignant tumours has not yet been fully elucidated. It is well known that LF has a high affinity for iron, which has been considered an essential nutrient for cells that are dividing rapidly such as tumour cells, taking part in various metabolic processes such as oxydative phosphorylation and RNA and DNA synthesis [1,5]. Therefore, neoplastic elements should be able to produce LF in order to make a greater amount of iron available for their turnover, similarly to that elsewhere suggested [7,20]. Alternatively, the localization of LF in malignant cells may not reflect an intracellular synthesis, reflecting instead the degree of transmembranous iron transfer as the consequence of defective or functionally impaired LF-receptors, already documented on the surface of target cells as well as in human neoplastic cell lines [21].

In our casuistry, the LF immunostaining was never founded in relation to the site, grade and stage of malignant tumours, excluding thus its role as predictive or prognostic neoplastic markers. Nevertheless, the immunohistochemical evidence of LF was largely confined to differentiated carcinomatous histotypes, such as differentiated glandular carcinomas of the stomach, colon and gallbladder, while anaplastic and undifferentiated carcinomas were always unstained; consequently, it may be suggested a role for LF as marker of glandular or acinar differentiation, similarly to that already pointed out in other malignancies [20,22,23].

Conclusion

The protective effects of LF have been demonstrated on chemically induced tumors of rodents [1]; moreover, it has been previously reported that LF is able to inhibit the development of experimental metastases in mice, mainly by an increase of NK cells and T lymphocytes expressing CD8, CD4 and IFNy [24]. Meanwhile, other potential mechanisms have been suggested regarding the role of LF in the process of human carcinogenesis, including induction of programmed cell death, prevention of angiogenesis and regulation of cell cycle protein expression [25,26]. In fact, LF is able to trigger the apoptotic process by the activation of caspases 3 and 8 as well as the FAS signaling pathway [24]; on the other hand, LF was also shown to inhibit tumour-initiated angiogenesis in vitro and in vivo, possibly by blocking endothelial function and inducing IL-18 production [25]. Moreover, it has been reported that LF promoted growth ARGHest either at the G1 to S transition in breast cancer cells [8] as well as at the G0-G1 checkpoint in oral and neck cancer cells [27]; finally, LF demonstrated its ability to regulate cell growth by controlling the level of retinoblastoma protein, a key tumour suppressor involved in cell cycle progression [28]. Nevertheless, whatever was the mechanism ofaction of LF in tumours; we probably still require additional investigations about the opportunity for new applications of LF in cancer, mainly regarding its nutraceutical function as well as its ability to potentiate chemotherapy.


 

Comments

Post a Comment

Popular posts from this blog

Milk Curd Syndrome: A Forgotten Entity_Juniper Publishers

Image
ADVANCED RESEARCH IN GASTROENTEROLOGY & HEPATOLOGY JUNIPER PUBLISHERS   Authored by Kashish Khanna Abstract A full term neonatal baby girl presented with a lumbosacral meningomyelocele and underwent successful excision and repair. In the postoperative period, she developed abdominal distension, bilious vomiting and did not pass stools. Conservative management for ileus/intestinal obstruction failed. The abdominal exploration revealed milk curd syndrome (MCS) as a cause of intestinal obstruction. This article highlights the varied presentation of MCS and salient features to differentiate it from other causes of neonatal intestinal obstruction. Keywords: Neonatal intestinal obstruction; Milk curd syndrome; Inspissated milk syndrome; Milk plug syndrome Abbreviations: MCS: Milk Curd Syndrome; SBE: Small Bowel Obstruction; NEC: Necrotising Enterocolitis; MMC: Meningomyelocele; TCA: Total Colonic Aganglionosis ...
Read more

A Modified Sequential Regimen of Helicobacterpylori Treatment Enforced by Bacillus clausii and Zinc Carnosine Complex Yields High Eradication Rates_Juniper Publishers

Image
  ADVANCED RESEARCH IN GASTROENTEROLOGY & HEPATOLOGY JUNIPER PUBLISHERS   Authored by Dajani AI      Abstract Introduction: Over the past decade a worldwide trend of decline in the cure rates of Helicobacter pylori is observed. Current eradication rates achieved by the standard triple therapy are below 70%. Sequential therapy had provided a potential alternative that would compensate for the unmet performance of triple therapy. Despite its superiority to triple therapy, the excellent results reported initially were not reproduced by other investigators work. Adding adjuvant agents was also found to improve further the success rate of eradication. Probiotics emerged as a useful adjunct in treatment and prophylaxis of Helicobacter pylori infection. The nutritional supplement Zinc carnosine complex is another adjuvant which is believed to add value to the treatment. Patients and method: an open label randomized observational clinical study ...
Read more

Updating on Neuroendocrine Tumors New Clinical Evidence in the Search of the Ideal Treatment Sequence_Juniper Publishers

Image
ADVANCED RESEARCH IN GASTROENTEROLOGY & HEPATOLOGY JUNIPER PUBLISHERS Authored by Juan Manuel O'Connor   Introduction Neuroendocrine tumors (NETs) represent a heterogeneous clinical entity with an increasing incidence as shown by the different registers available. As opposed to other solid tumors, NETs represent a challenge, not only from the diagnostic standpoint but also in terms of treatment strategies. According to the data published by our Working group, ARGENTUM GROUP [ 1 ], with more than 600 patients assessed, roughly 60% of the cases present with metastatic disease from the onset. The reason why the incidence of advanced disease is high since early onset may be due to a bias, for most of the physicians in our Group are oncologists. Moreover, about 20% of the patients included present poorly differentiated NETs, a heterogeneous subgroup, with high risk and poor outcome according to the different series reported. G grading...
Read more